Polymorphism in exon 7 of the endothelial nitric oxide synthase gene is associated with low incidence of microvascular damage in type 1 diabetic neuropathy

Central European Journal of Biology

Volumn 4, Issue 4, 2009, Pages 521-527

  Heltianu, Constantina ^a   Manea, Simona Adriana ^a   Guja, Cristian ^b   Robciuc, Alexandra ^a   Ionescu Tirgoviste, Constantin ^b  

^a INSTITUTE OF CELLULAR BIOLOGY AND PATHOLOGY NICOLAE SIMIONESCU   (Romania)

^b Institute of Diabetes   (Romania)

Author keywords

eNOS polymorphisms; Low molecular weight AGEs; Neuropathy; Nitric oxide; Type 1 diabetes

Indexed keywords

EID: 76149114908     PISSN: 1895104X     EISSN: 16443632     Source Type: Journal    
DOI: 10.2478/s11535-009-0051-z     Document Type: Article

References (18)

1. Costacou T., Chang Y., Ferrell R. E., Orchard T. J., Identifying genetic susceptibilities to diabetesrelated complications among individuals at low risk of complications: An application of tree-structured survival analysis, Am. J. Epidemiol., 2006, 164, 862-872.
2. Taverna M. J., Sola A., Guyot-Argenton C., Pacher N., Bruzzo F., Chevalier A., et al., eNOS4 polymorphism of the endothelial nitric oxide synthase predicts risk for severe diabetic retinopathy, Diabet. Med., 2002, 19, 240-245.
3. Taverna M. J., Elgrably F., Selmi H., Selam J. L., Slama G., The T-786C and C774T endothelial nitric oxide synthase gene polymorphisms independently affect the onset pattern of severe diabetic retinopathy, Nitric Oxide, 2005, 13, 88-92.
4. Zanchi A., Moczulski D. K., Hanna L. S., Wantman M., Warram J. H., Krolewski A. S., Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism, Kidney Int., 2000, 57, 405-413.
5. Chiarelli F., Cipollone F., Romano F., Tumini S., Costantini F., di Ricco L., et al., Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: relation to glomerular hyperfiltration, Diabetes, 2000, 49, 1258-1263.
6. Sharp P. S., Rainbow S., Mukherjee S., Serum levels of low molecular weight advanced glycation end products in diabetic subjects, Diabet. Med., 2003, 20, 575-579.
7. Moncada S., Higgs E. A., Molecular mechanisms and therapeutic strategies related to nitric oxide, FASEB J., 1995, 9, 1319-1330.
8. Zochodne D. W., Levy D., Nitric oxide in damage, disease and repair of the peripheral nervous system, Cell. Mol. Biol. (Noisy-le-grand), 2005, 51, 255-267.
9. Heltianu C., Manea S. A., Guja C., Mihai C., Ionescu-Tirgoviste C., Correlation of low molecular weight advanced glycation end products and nitric oxide metabolites with chronic complications in type 1 diabetic patients, Cent. Eur. J. Biol., 2008, 3, 243-249.
10. Green A., Gale E. A., Patterson C. C., Incidence of childhood onset insulin-dependent diabetes mellitus: the EURODIAB ACE Study, Lancet, 1992, 339, 905-909.
11. Guja C., Ionescu-Tirgoviste C., Chronic angiopathic complications in type 1 diabetes across Europe as a result of EURODIAB multicentric study, In: Simionescu M., Sima A., Popov D., (Eds), Cellular dysfunction in atherosclerosis and diabetes-reports from bench to bedside, Romanian Academy Publishing House, Bucharest, 2004, 408-421.
12. Heltianu C., Costache G., Azibi K., Poenaru L., Simionescu M., Endothelial nitric oxide synthase gene polymorphism in Fabry's disease, Clin. Genet., 2002, 61, 423-429.
13. Tsukada T., Yokoyama K., Arai T., Takemoto F., Hara S., Yamada A., et al., Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans, Biochem. Biophys. Res. Comm., 1998, 245, 190-193.
14. Ahsan A., Mohd G., Norboo T., Baig M. A., Pasha M. A., Heterozygotes of NOS3 polymorphisms contribute to reduced nitrogen oxides in high-altitude pulmonary edema, Chest, 2006, 130, 1511-1519.
15. Pereira E. C., Ferderbar S., Bertolami M. C., Faludi A. A., Monte O., Xavier H. T., et al., Biomarkers of oxidative stress and endothelial dysfunction in glucose intolerance and diabetes mellitus, Clin. Biochem., 2008, 41, 1454-1460.
16. Choi K. C., Kim N. H., An M. R., Kang D. G., Kim S. W., Lee J., Alterations of intrarenal renin-angiotensin and nitric oxide systems in streptozotocin-induced diabetic rats, Kidney Int., 1997, Suppl. 60, 23-27.
17. Cameron N. E., Eaton S. E., Cotter M. A., Tesfaye S., Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy, Diabetologia, 2001, 44, 1973-1988.
18. Beleslin-Cokic B. B., Cokic V. P., Yu X., Weksler B. B., Schechter A. N., Noguchi C. T., Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells, Blood, 2004, 104, 2073-2080.